Liver Transplantation (LT)
7
2
2
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 7 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (7)
Mental Health Outcomes and Psychological Evaluation After Liver Transplantation
Isavuconazole Therapeutic Drug Monitoring in Transplant Recipients
Avoiding Recooling After Normothermic Machine Perfusion in Liver Transplantation
Physical and Cognitive Outcomes After Post-Transplant Physiotherapy in Liver Transplant Recipients
Restrictive Fluid Management In Liver Transplantation (REFIL)
New Biomarkers for Organ Viability Assessment During Hypothermic Machine Perfusion in Liver Transplantation: the Role of Extemporaneous Histological Examination.
Liver Transplant for Hepatocellular Carcinoma